Pages that link to "Q81321954"

The following pages link to Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats (Q81321954):

Displaying 43 items.

• Neuropeptide Y Y2 receptor in health and disease (Q24648453) (← links)
• The L-Cell in Nutritional Sensing and the Regulation of Appetite (Q26799942) (← links)
• Gut hormones and the regulation of energy homeostasis (Q28278826) (← links)
• Melanocortin neurons: Multiple routes to regulation of metabolism (Q30234481) (← links)
• Bang-bang control of feeding: role of hypothalamic and satiety signals (Q33285866) (← links)
• Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice (Q33521218) (← links)
• Obesity treatment: novel peripheral targets (Q33607971) (← links)
• Appetite control and energy balance regulation in the modern world: reward-driven brain overrides repletion signals (Q33725899) (← links)
• Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects (Q34159708) (← links)
• Role of capsaicin-sensitive peripheral sensory neurons in anorexic responses to intravenous infusions of cholecystokinin, peptide YY-(3-36), and glucagon-like peptide-1 in rats (Q34356012) (← links)
• The vagus nerve, food intake and obesity (Q34778864) (← links)
• NPY receptors as potential targets for anti-obesity drug development (Q35130522) (← links)
• Hedonic and incentive signals for body weight control (Q35132233) (← links)
• Gastrointestinal regulation of food intake (Q35251043) (← links)
• Vitamin B12 conjugation of peptide-YY(3-36) decreases food intake compared to native peptide-YY(3-36) upon subcutaneous administration in male rats (Q35436033) (← links)
• Effects of leptin replacement alone and with exendin-4 on food intake and weight regain in weight-reduced diet-induced obese rats (Q36042116) (← links)
• Peptide YY3-36 decreases reinstatement of high-fat food seeking during dieting in a rat relapse model (Q36178633) (← links)
• Eating for pleasure or calories (Q36372944) (← links)
• PYY(3-36) induces Fos in the arcuate nucleus and in both catecholaminergic and non-catecholaminergic neurons in the nucleus tractus solitarius of rats (Q36416123) (← links)
• Vagal and hormonal gut-brain communication: from satiation to satisfaction (Q36744165) (← links)
• Leptin extends the anorectic effects of chronic PYY(3-36) administration in ad libitum-fed rats (Q36808143) (← links)
• Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats (Q36846722) (← links)
• Gut hormones as potential new targets for appetite regulation and the treatment of obesity (Q37057996) (← links)
• Strategies for preventing type 2 diabetes: an update for clinicians (Q37117608) (← links)
• Central and peripheral regulation of food intake and physical activity: pathways and genes (Q37204432) (← links)
• An expanded view of energy homeostasis: neural integration of metabolic, cognitive, and emotional drives to eat. (Q37395143) (← links)
• GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents (Q37629291) (← links)
• PYY(1-36) is the major form of PYY in rat distal small intestine: quantification using high-resolution mass spectrometry (Q37677910) (← links)
• Intestinal feedback signaling and satiety (Q37840465) (← links)
• The neuropeptide Y system: Pathophysiological and therapeutic implications in obesity and cancer (Q37857947) (← links)
• Metabolic surgery-principles and current concepts (Q37922651) (← links)
• Translational and therapeutic potential of oxytocin as an anti-obesity strategy: Insights from rodents, nonhuman primates and humans. (Q38503454) (← links)
• Examining acute and chronic effects of short- and long-chain fatty acids on peptide YY (PYY) gene expression, cellular storage and secretion in STC-1 cells. (Q39289995) (← links)
• Comparison of the effects of Roux-en-Y gastric bypass and ileal transposition surgeries on food intake, body weight, and circulating peptide YY concentrations in rats. (Q43664359) (← links)
• Mesoporous silicon (PSi) for sustained peptide delivery: effect of psi microparticle surface chemistry on peptide YY3-36 release. (Q45786266) (← links)
• Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats (Q47427740) (← links)
• Appetite-Related Gut Peptides in Obesity and Binge Eating Disorder (Q49147173) (← links)
• Type 2 diabetes control in a nonobese rat model using sleeve gastrectomy with duodenal-jejunal bypass (SGDJB). (Q51352546) (← links)
• Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin (Q58617448) (← links)
• Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion (Q61974730) (← links)
• The Influence of the Gut Microbiome on Host Metabolism Through the Regulation of Gut Hormone Release (Q64108732) (← links)
• [New approaches in obesity treatment: the gastrointestinal tract as an endocrine organ] (Q80204033) (← links)
• Modified Peptide YY Molecule Attenuates the Activity of NPY/AgRP Neurons and Reduces Food Intake in Male Mice (Q91914196) (← links)